These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38200678)

  • 41. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 42. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
    Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detection of colorectal advanced neoplasms among the cancer screening population in urban areas of Henan Province and analysis on its influencing factors].
    Guo LW; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Wang H; Wang XY; Liu SZ; Zhang SK
    Zhonghua Zhong Liu Za Zhi; 2024 Aug; 46(8):794-800. PubMed ID: 39143802
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50.
    Yen T; Scolaro J; Montminy E; Karlitz JJ; Wani S; Patel SG;
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):827-829.e3. PubMed ID: 34800736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermediate-risk patients with three to four small adenomas should be considered low risk for colorectal cancer screening.
    Pérez-Cuadrado-Robles E; Torrella-Cortés E; Bebia-Conesa P; Quesada-Vázquez N; Rodrigo-Agudo JL; Chacón-Martínez S; López-Martín A; Esteban-Delgado P; Pérez-Cuadrado-Martínez E; Pérez-Riquelme F
    Dig Endosc; 2016 May; 28(4):450-455. PubMed ID: 26538148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study.
    Zhao S; Wang S; Pan P; Xia T; Wang R; Cai Q; Chang X; Yang F; Gu L; He Z; Wu J; Meng Q; Wang T; Fang Q; Mou X; Yu H; Zheng J; Bai C; Zou Y; Chen D; Zou X; Ren X; Xu L; Yao P; Xiong G; Shu X; Dang T; Zhang L; Wang W; Kang S; Cao H; Gong A; Li J; Zhang H; Du Y; Li Z; Bai Y;
    J Hematol Oncol; 2022 Nov; 15(1):162. PubMed ID: 36333749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of recurrent advanced colorectal neoplasia in individuals with baseline non-advanced neoplasia followed up at 5 vs 7-10 years.
    Wong MCS; Leung EY; Chun SCC; Deng Y; Lam T; Tang RSY; Huang J
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2122-2129. PubMed ID: 37771047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals.
    Ng SC; Ching JY; Chan VC; Wong MC; Tang R; Wong S; Luk AK; Lam TY; Gao Q; Chan AW; Wu JC; Chan FK; Lau JY; Sung JJ
    Aliment Pharmacol Ther; 2015 Jan; 41(1):108-15. PubMed ID: 25339583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
    Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
    Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcome of 12-month surveillance colonoscopy in high-risk patients in the National Health Service Bowel Cancer Screening Programme.
    Lee TJ; Nickerson C; Goddard AF; Rees CJ; McNally RJ; Rutter MD
    Colorectal Dis; 2013 Aug; 15(8):e435-42. PubMed ID: 23663559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Head-to-head comparison of a risk-adapted screening strategy using various risk prediction models in detecting colorectal neoplasm.
    Lu M; Zhang Y; Cai J; Lu B; Luo C; Chen H; Dai M
    J Gastroenterol Hepatol; 2022 Jul; 37(7):1244-1252. PubMed ID: 35263809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
    Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
    Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
    Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
    [No Abstract]   [Full Text] [Related]  

  • 60. Computed tomographic colonography for colorectal cancer screening: risk factors for the detection of advanced neoplasia.
    Hassan C; Pooler BD; Kim DH; Rinaldi A; Repici A; Pickhardt PJ
    Cancer; 2013 Jul; 119(14):2549-54. PubMed ID: 23754679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.